Zhe Chen
Impact in
- Obstetrics and Gynecology top 5%
- COVID-19 Impact on Reproduction
- Pharmacology top 5%
- Pharmacological Effects of Natural Compounds
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 3
- Rheumatology 12
- Rheumatoid Arthritis Research and Therapies 8
- Co-authors
- Shenghao Tu (20 shared papers)Kai Qin (10 shared papers)Ying Huang (14 shared papers)Weiji Lin (11 shared papers)Xin Ba (11 shared papers)Pan Shen (10 shared papers)Liang Han (5 shared papers)Youwei Yan (2 shared papers)
- Journals
- Evidence-based Complementary and Alternative Medicine (9 papers)Frontiers in Immunology (3 papers)Medicine (2 papers)Drug Design Development and Therapy (2 papers)Frontiers in Medicine (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Zhe Chen
81 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 139
- Obstetrics and Gynecology 126
- Pharmacology 80
- Complementary and alternative medicine 70
- Rheumatology 109
- Infectious Diseases 117
Countries citing papers authored by Zhe Chen
This map shows the geographic impact of Zhe Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhe Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhe Chen more than expected).
Fields of papers citing papers by Zhe Chen
This network shows the impact of papers produced by Zhe Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhe Chen. The network helps show where Zhe Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhe Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 179 | |
| 2 | 2021 | 100 | |
| 3 | 2020 | 95 | |
| 4 | 2020 | 92 | |
| 5 | 2006 | 46 | |
| 6 | 2019 | 42 | |
| 7 | 2023 | 41 | |
| 8 | 2003 | 38 | |
| 9 | 2012 | 29 | |
| 10 | 2015 | 29 | |
| 11 | 2015 | 27 | |
| 12 | 2019 | 25 | |
| 13 | Effect of obesity and hyperglycemia on benign prostatic hyperplasia in elderly patients with newly diagnosed type 2 diabetes. | 2015 | 25 |
| 14 | 2017 | 24 | |
| 15 | 2020 | 21 | |
| 16 | 2017 | 20 | |
| 17 | 2014 | 20 | |
| 18 | 2019 | 19 | |
| 19 | 2016 | 18 | |
| 20 | 2023 | 17 |
About Zhe Chen
Zhe Chen is a scholar working on Molecular Biology, Rheumatology, Oncology, Complementary and alternative medicine and Parasitology, having authored 84 papers that have together received 1.3k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (8 papers), Parasites and Host Interactions (6 papers), Gout, Hyperuricemia, Uric Acid (4 papers), Cancer Mechanisms and Therapy (4 papers), Traditional Chinese Medicine Studies (4 papers), COVID-19 Clinical Research Studies (3 papers), Cytokine Signaling Pathways and Interactions (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). The work is most often cited by research in Obstetrics and Gynecology (126 citations), Pharmacology (80 citations), Complementary and alternative medicine (70 citations), Rheumatology (109 citations) and Infectious Diseases (117 citations). Zhe Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Shenghao Tu, Kai Qin, Ying Huang, Weiji Lin, Xin Ba, Pan Shen, Liang Han, Youwei Yan, Xuan Deng and Xiaoquan Lai. Their work appears in journals such as Evidence-based Complementary and Alternative Medicine, Frontiers in Immunology, Medicine, Drug Design Development and Therapy and Frontiers in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.